PB2014: A PHASE 2/3 TRIAL OF ORAL AZACITIDINE IN PATIENTS WITH LOW- OR INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROMES

ABSTRACT:

SUBMITTER: Garcia-Manero G 

PROVIDER: S-EPMC10430382 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature